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ABSTRACT 
Objective: Ayurvedic/herbal medicines are easy to access and hence are becoming alternative for obesity management. The present study was 
done to find out the availability of herbal anti-obesity drugs in pharmacy and online website.  
Methods: A cross-sectional survey on ayurvedic/herbal drugs in local pharmacies was conducted in order to obtain data for accessible marketed 
anti-obesity formulations. A total of 15 pharmacies and 40 online websites were selected randomly and data available with respect to the anti-
obesity formulations using predefined criteria was collected.  
Results: The information revealed the presence of 65 formulations on these two outlets. The study showed 20 (31%) products were available in 
pharmacies, 15 (23%) were available only through online shopping while 30 (46%) products were available for marketing at both the places. The 
study results showed that highest 41% of the herbal medicine have triphala followed by garcinia and guggul as part of the composition or used 
individually. As per pharmacist, 60-70% of herbal anti-obesity drugs are being purchased without a prescription. There are many online websites 
available, selling herbal anti-obesity drugs with titles of safety and guaranteed weight loss.  
Conclusion: The study revealed the rampant availability of ayurvedic/herbal drugs in the market possibly due to the attractive names, tall claims 
and assumed safety about these drugs.  
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In the recent years, obesity has become a major health problem 
worldwide affecting people across all ages, sex, ethnicities, and 
races. Its prevalence has been increasing at an alarming rate. It is a 
disease involving severe metabolic disturbances affecting almost all 
systems in the body [1]. The current treatment modalities available 
to manage obesity carry either high cost or serious side effects [2]. 
Against this background, herbal anti-obesity products attract users 
with their health claims and assumed safety along with easy 
availability and extensive marketing. Although there are clinical 
studies supporting the beneficial effect of some herbal medicines in 
weight reduction, these medicines can have unpredictable levels of 
active ingredients and can, therefore, produce effects of varying 
degrees [3]. Further, the herbal products can sometimes cause direct 
toxicity or adverse interactions with concurrent medications [4]. 
Some previously performed pharmacoepidemiology studies have 
addressed some of the issues and have provided evidence-based 
data on the use of marketed ayurvedic drugs for diabetes [5, 6] 
However, no such study has been reported so far on marketed anti-
obesity products. With this background, the present study was 
planned to collect information on ayurvedic/herbal medicines 
presently available in the market as promising in the management 
and treatment of obesity. 
Among health-care professionals, pharmacists are in a position to 
influence consumers as they are easily accessible to consumers [7]. The 
online available market is an easy way for consumers to find information 
about drugs from selling to the experience of users. Hence, we focused 
our study on local pharmacies and online marketing. 
A cross-sectional study was carried out on the availability of anti-
obesity ayurvedic/herbal products in 15 local pharmacies and online 
shopping during the month of December 2015. The local pharmacies 
were selected using convenient sampling. The pharmacists were asked 
to show the containers of ayurvedic/herbal products available with 
them for obesity treatment. The information available on the labels of 
the containers was captured without opening them. The online study 
was carried out using search terms viz. ‘ayurvedic/herbal medicines 
for obesity OR weight loss.' The products with images and required 
information were only included in the study. 
In both the cases, the following information was collected for each 
product.  
• Name of the product 
• Name of the manufacturer 
• Availability (pharmacy or online or both) 
• Type of product (classical or Patent and Proprietary [P and P]) 
• Ingredients 
• Formulation type (capsules, tablets, churna/powder, syrup) 
• Dosage 
• Cost 
• Any other recommendation provided with the product 
In case of the products available in pharmacies, in addition to the 
above information, the pharmacists/shopkeepers were also asked 
about the details of the sale. The testimonials received were 
documented in case of products available online.  
The results are expressed in numbers (percentage). 
Total 65 ayurvedic/herbal anti-obesity products were available in 
pharmacies, online or both. Of these, 20 (31%) products were 
named based on the ingredients (e. g. triphala, garcinia, shuddh 
guggul etc.) and 45 (69%) products were given attractive names 
based on their claimed efficacy in obesity (e. g. lofat, slimtrim etc.). 
These products were manufactured by both top brand Pharma 
companies and local manufacturers. 
Twenty (31%) products were available in pharmacies, 15 (23%) 
were available only through online shopping while 30 (46%) 
products were available for marketing at both the places. Of the 65 
products, only 8 (12%) were described in classical texts and rest 57 
(88%) were P and P products. 
These products had minimum 1 to maximum 20 ingredients. Out of 
the formulations, triphala was found in the composition of 27(41%) 
of products. Following triphala, garcinia, guggul, and green tea were 
commonly seen ingredients (table 1). 
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Around 32 (50%) were found in capsule form, 21 (32%) found in 
tablets, 8 (12%) churna/powder whereas 4 (6%) were available in 
syrup form. 
The cost of the drug showed wide variation. The calculated per day 
cost of 42 (65%) drugs was found to be between Rs. 1-12 while the 
cost of 23 (35%) drugs was between Rs. 30-70 a day. The powder 
form was found cheaper as compared to tablets and capsules. 
In case of other recommendations, information about the dosage 
schedule and the adjuvant was available in most of the products. 
While on some products, the dosage schedule was provided with 
respect to morning-evening pattern, in case of some products it was 
given in relation with a meal. Interestingly, only 15 (8%) products 
mentioned that the dosage should be administered as per the 
recommendation of the physician. The commonly prescribed 
adjuvants were lukewarm water, milk, honey or normal water. 
Around 65% of products recommended another regimen like diet, 
exercise, moderate physical activity, yoga or intake of low-calorie 
food along with the product.  
The interview of the pharmacists/shopkeepers revealed that in 70-
80 % instances the products were self-medicated i.e. without 
prescriptions. The average usage by the patients is for a period of 
30-90 d. The average sale of anti-obesity products was around 70-80 
units per month and in spite of this reasonable size of the sale, the 
pharmacists did not receive any adverse event (table 2). In case of 
products available online, testimonials (by the patients narrating 
their experiences about the product, mostly positive) were found in 
70% products. 
 
Table 1: Frequency of ingredients in anti-obesity formulations 
Name of ingredients  Present in formulations(N) 
Triphala 27 
Garcinia combogia 19 
Commiphoramukul 17 
Shuddha Shilajit 10 
Piper longum (Pippali) 8 
Camellia sinensis (Green tea) 7 
Coffea arabica (Green coffee) 6 
Loh bhasma 6 
Plumbago zeylanica (Chitak) 4 
Cinnamon verum (Dalchini) 3 
Apple cidar 3 
Trigonella foenum (Fenugreek) 3 
Medohar 2 
Gymnema sylvestrae (Meshshringi) 2 
Capsicum annuum (Chilli) 2 
 
Table 2: Details of sale of marketed anti-obesity drugs 
S. 
No. 





Prescribed? Self-recommended? Record of outcome/adverse 
events? 
1.  170-200 15days-
3months 
40%  Usually (among 
youngsters) 
No  
2.  700-1000 Months-yr. If with other complications 50% Don’t know 
3.  Timely/seasonal (500) Up to 6 mo 60%  40% (youngsters and 
females) 
Never  
4.  500-700 2 mo If with other complications 
(30%) 
70% They don’t need to as it is job of 
doctors 
5.  1000-2000 3 mo to yr. 70% 20-30% No  
6.  700 3 mo If with other complications 60% No  
7.  200-700 2-6 mo 20% 80% No  
8.  150 2-4 mo 5-10% (youngsters n 
females) 
Usually  No  
9.  100-200 15 d-1 yr. Usually  Sometimes  No  
10.  500 3 mo Never  All  No  
11.  60-100 3 mo 5-10% 90% No 
12.  200 2-3 mo 10-20% 70-80% No 
13.  70-80 2 mo 15-20% Maximum (80%) No 
14.  65-78 3months Not observed Not observed No 
15.  100-120 6 mo-yr. 10% All almost No 
 
 
Fig. 1: Dosage schedule of anti-obesity products 
 
The present study was carried to study the availability and various 
details of ayurvedic/herbal anti-obesity drugs. We observed huge 
availability of these drugs in local pharmacies as well as through 
online marketing. Our finding highlights the strong belief of Indian 
population in ayruveda/herbal treatments. It also reflects the 
consumer’s psychology viz. easy access to medicines and assumed 
safety of herbal drugs. 
It was interesting to note that the weight reduction products were 
given attractive names like “Minus”, “Beautiful Slim Body”, “Ayu 
Lean Tone” and “Quick Slim” etc. to lure consumers. The terms such 
as “fast and quick”, “best quality”, “vegetarian” were also seen on the 
containers which fascinate the consumers further. The powder form 
of products was found cheaper compared to capsules or tablets. This 
may be because of making charges, packing or encapsulation 
charged by companies. Triphala was found to be the most common 
ingredient of these products irrespective of the dosage form. Even 
the individual ingredients of triphala were used in the products. 
Since most of these products fall in the P and P category, the 
rationale for selection of ingredients remains unknown. The range of 
cost of the products was wide and largely depended on branding and 
appearance. There was incontinency with respect to the 
administration cycles of the medicines and the adjuvants. It is not 
clear how the dosage schedule can vary for a single disease entity to 
such an extent. 
All drugs claimed benefits such as “reduce weight fast”, “weight 
reduction formula” and “an herbal drug for weight loss”, but not a 
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single label displayed information about the precise mechanism of 
the product. The mechanisms mentioned on the labels include vague 
terms like “promotes metabolism”, “curbs appetite”, based on 
“ayurvedic beliefs”, “reduces calorie intake”, “reduces fat 
accumulation”, “speeds up fat burning mechanism” etc. However, 
whether these mechanisms are backed up by any scientific evidence 
poses a question. 
Almost all products mention the instruction for use viz. ‘as directed 
by a physician or a qualified health professional,' still in 70-80% 
instances the products were self-medicated as revealed by the 
information provided by the pharmacists. There are high chances of 
self-diagnosis in a condition like obesity. It becomes crucial in such 
cases to educate the consumers about the potential adverse effects 
and interactions with other medicines as well as the authenticity of 
therapeutic claims. There is a need to create awareness among the 
society about the safe usage of ayurvedic/herbal medicines, which 
can include instructions such as always read carefully the 
information provided by the manufacturer of the product or leaflets 
prior to using any ayurvedic/herbal/nutritional products, report the 
physician any untoward effect observed during the course of 
treatment, not to rely on the testimonials available online, etc. 
The medicines are being purchased without prescription or 
recommendation by a physician. It may lead to expose consumers to 
the various possible hazard. This poses further apprehension as 
obesity is a high-risk factor for various metabolic disorders. It has to 
be also noted that the selection of the medicines, dosage and the 
ancillary measures ideally should be done by the physician based on 
the clinical condition of the patient. The availability of these 
products ‘over the counter’ therefore should be reconsidered. 
Thus, our study once again reveals various issues regarding the 
marketed ayurvedic/herbal drugs pointed out in earlier studies such 
as reliance on the information provided by the pharmacists for 
purchase, availability of the resource information over the internet 
and other informal ways like testimonials, lack of record of herbal 
medicines and absence of stringent regulatory system [5, 6]. 
Extensive Pharmaco-epidemiology studies are therefore obligatory 
to generate data on usage, safety, and efficacy of anti-obesity drugs. 
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